3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Malignancy: new trials by email Literature Review of Malignancy trials Research Report on Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors CYT-0851, CYT-0851 in combination with gemcitabine, CYT-0851 in combination with capecitabine - Malignancy, Non-hodgkin Lymphoma | Phase 1 / Phase 2 | Completed | Cyteir Therapeutics, Inc. | 169 | 2019-10-09 | 2024-12-24 |
| Abatacept as GVHD Prophylaxis Phase 2 Abatacept, placebo - Graft vs Host Disease, Malignancy | Phase 2 | Completed | Boston Children's Hospital | 186 | 2013-02-01 | 2025-12-11 |
| Allogeneic Transplantation From Related Haploidentical Donors non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin, Cyclosporine - Blood Cancer, Leukemia | Phase 2 | Completed | Stanford University | 16 | 2000-08-01 | 2019-12-04 |
Neoplasms (3) · Graft vs Host Disease (2) · Breast Neoplasms (1) · Head and Neck Neoplasms (1) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Leukemia (1) · Lymphoma, Follicular (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Sarcoma (1) · Small Cell Lung Carcinoma (1)
Immune System Diseases (3) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoproliferative Disorders (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Adnexal Diseases (1) · Blood Protein Disorders (1) · Breast Diseases (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1)
Abatacept (1) · Acetaminophen (1) · Antilymphocyte Serum (1) · Bendamustine Hydrochloride (1) · Capecitabine (1) · Cyclosporine (1) · Diphenhydramine (1) · Gemcitabine (1) · Granulocyte Colony-Stimulating Factor (1) · Hydrocortisone (1) · Methylprednisolone (1) · Methylprednisolone Acetate (1) · Methylprednisolone Hemisuccinate (1) · Mycophenolic Acid (1) · Peripheral Blood Stem Cell Transplantation (1)
Boston Children's Hospital (1) · Cyteir Therapeutics, Inc. (1) · Stanford University (1)
United States (3) · Canada (1)
Leslie Kean, MD, PhD (1) · Markus Renschler, MD (1) · Robert Lowsky (1)